مرکز تحقیقات عفونت‌های منتقله از خون

EN | FA

مقالات چاپی

دوشنبه ، 13 آبان 1398

  1. SARS-CoV-2 infection and increasing autoimmune disorders among ICU-hospitalized COVID-19 patients, International Journal of Rheumatic Diseases, November 2023, View Article
  2. Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran, Journal of NeuroVirology, October 2023, View Article
  3. Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL), Molecular biology reports, September 2023, View Article
  4. Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo, Journal of NeuroVirology, August 2023, View Article
  5. Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region, Microbial Pathogenesis, August 2023, View Article
  6. Influence of sexually transmitted infections on the cervical cytological abnormalities among Iranian women: A cross-sectional study, International Journal of Reproductive BioMedicine, July 2023, View Article
  7. Underlying diseases, nutritional assessment, viral incidence and HBV immunity status in patients undergoing hemodialysis, Journal of Renal Endocrinology, June 2023, View Article
  8. Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study, Journal of Virus Eradication, June 2023, View Article
  9. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL), Critical Reviews in Clinical Laboratory Sciences, May 2023, View Article
  10. Development of a Novel HTLV‑1 Protease: Human Fcγ1 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System, Applied Biochemistry and Biotechnology, March 2023, View Article
  11. Immigrating and vicinity are not risk factors in the prevalence and transmission rate of human T-lymphotropic virus type 1: A Survey in an endemic region of Iran and Afghan refugees, PLOS Global Public Health, January 2023, View Article
  12. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region, Gene, December 2022, View Article
  13. Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv:mFcγ2a) for HTLV-1 vaccine development, Life Sciences, November 2022, View Article
  14. Prevalence and Genotype Distribution of Human Papillomavirus in a Population of Iranian Men, Journal of Mazandaran University of Medical Sciences, September 2022, View Article
  15. Coevolution of HTLV-1-HBZ, Tax, and proviral load with host IRF-1 and CCNA-2 in HAM/TSP patients, Infection, Genetics and Evolution, September 2022, View Article
  16. Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran, Hepatitis Monthly, August 2022, View Article
  17. Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection, Gene, August 2022, View Article
  18. TAX and HBZ: hFc Ɣ 1 proteins as targets for passive immunotherapy, Iranian Journal of Basic Medical Sciences, May 2022, View Article
  19. Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran, Viruses, April 2022, View Article
  20. Possible deterioration of Apolipoproteins expression by HTLV-1 infection in favor of infected leukemic cells in adult T-cell leukemia/lymphoma (ATLL), Gene Reports, March 2022,  View Article
  21. Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy, Journal of NeuroVirology, December 2021, View Article
  22. Combination of auraptene and arsenic trioxide induces apoptosis and cellular accumulation in the subG1 phase in adult T-cell leukemia cells, Iranian Journal of Basic Medical Sciences, December 2021, View Article
  23. Global and national trends toward hepatitis in COVID-19 era: Emerging pandemic and neglect of other diseases, Hepatitis Monthly, October 2021, View Article
  24. HTLV-1 oncovirus-host interactions: From entry to the manifestation of associated diseases, Reviews in Medical Virology, November 2021, View Article
  25. A Computerized Platform for Screening and Management of Psychological Characteristics of Healthcare Providers during Novel Coronavirus Infection. Iranian Journal of Medical Sciences, September-October 2021, View Article
  26. Prevalence of Different Human Papillomavirus Genotypes and Their Relationship with Pap Smear Test Results in Mashhad, Iran. Journal of Mazandaran University of Medical Sciences, September 2021, View Article
  27. Hepatitis C virus infection awareness raising through HepC mobile application and Hepatobot, Journal of Biomedical Physics and Engineering, March 2021, View Article
  28. The Prevalence of Hepatitis C Virus (HCV) Infection and Genotypes in Patients with Hemophilia and Other Blood Coagulopathies in Mashhad, Iran, Archives of Medical Laboratory Sciences, March 2021, View Article
  29. Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: A systematic review and meta-analysis, World Journal of Hepatology, February 2021, View Article
  30. Hepatitis C rapid point-of-care testing and laboratory-based non-invasive assessment of liver fibrosis among drug abusers: an experience from Iran, Archives of Iranian Medicine, February 2021, View Article
  31. Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran, International Journal of Infectious Diseases, February 2021, View Article
  32. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad, Journal of NeuroVirology, December 2020, View Article
  33. Prevalence and associated risk factors of HTLV-1 and co-infections of blood-borne viruses in Birjand, Iran’s eastern border, Archives of Iranian Medicine, October 2020, View Article
  34. Telemedicine and computer-based technologies during coronavirus disease 2019 infection; a chance to educate and diagnose, Archives of Iranian Medicine, August 2020, View Article
  35. Occult hepatitis B virus infection prevalence among different populations of Iran: a systematic review and meta-analysis, Hepatitis Monthly, June 2020, View Article
  36. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects, Journal of NeuroVirology, June 2020, View Article
  37. Abnormal vitamin D and lipid profile in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, Molecular Biology Reports, January 2020, View Article
  38. HTLV-1-host interactions facilitate the manifestations of cardiovascular disease, Microbial Pathogenesis, September 2019 View Article
  39. Prediction of HCV load using genotype, liver biomarkers, and clinical symptoms by a mathematical model in patients with HCV infection, Microbiology and Immunology, August 2019 View Article
  40. Sero-prevalence of hepatitis D virus infection among hepatitis B surface antigen positive patients in Mashhad, Northeastern Iran, Modern Care Journal, July 2019 View Article
  41. Prevalence of hepatitis B serological markers among people who referred to a great laboratory in Neyshabur, northeast of Iran, International Journal of Infection, July 2019 View Article
  42. Evaluation of lipid profile and Tax mRNA expression in HTLV-1-infected patients with cardiovascular disease, Medical Journal of Mashhad University of Medical Sciences, May-June 2019 [in Farsi] View Article
  43. Frequency of viral transfusion-transmitted infections (TTIs) among resident and pilgrim blood donors in Mashhad, 2011, International Journal of Infection, April 2019 View Article
  44. High prevalence of HTLV-1 infection among hemodialysis patients in Neyshabur, northeast of Iran, International Journal of Infection, January 2019 View Article
  45. A survey of knowledge regarding viral hepatitis among general population of Mashhad, Iran: a population-based study, The Navid No Journal, Winter 2019 [in Farsi] View Article
  46. HTLV-1-host interactions on the development of adult T cell leukemia/ lymphoma: virus and host gene expressions, BMC Cancer, December 2018, View Article
  47. Is there any association between human T-lymphotropic virus type 1 (HTLV-1) infection and Behcet’s disease?, Rheumatology Research, September 2018, View Article
  48. Prevalence of HBsAg and Associated Risk Factors with Hepatitis B Infection among Pregnant Women in the Northeast of Iran, International Journal of Medical Laboratory (IJML), August 2018, View Article
  49. Genotype characteristic and phylogenetic analysis of hepatitis B virus in northeast-Iran, Infection, genetics and evolution, April  2018, View Article
  50. Rate of positive autoimmune markers in human lymphotropic virus type 1 carriers: a case control study from Iran, International Journal of Rheumatic Diseases, January 2018, View Article
  51. Distribution of hepatitis C virus genotypes in patients with major β-thalassemia in Mashhad, northeast Iran, Middle East Journal of Digestive Diseases, January 2018, View Article
  52. Evaluation of T regulatory lymphocytes transcription factors in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, Applied biochemistry and biotechnology, August 2017, View Article
  53. The prevalence of hepatitis B and C virus co-infection among a group of Iranian population, Modern Care Journal, April  2017, View Article
  54. Prevalence of hepatitis C virus infection in general population of Mashhad, northeastern Iran, Iranian Journal of Public Health, March 2017, View Article
  55. No Evidence of HIV Infection Among the General Population of Mashhad, Northeast of Iran, Jundishapur Journal of Microbiology, March 2017, View Article
  56. Prevalence of serological markers of hepatitis B Virus infection and its related risk factors in pregnant women referred to the Medical Diagnostic Laboratory of ACECR in Neyshabur, during 2014-2015, Journal of Neshabur University of Medical Sciences, Winter 2017, View Article
  57. Evaluation of non-viral surrogate markers as predictive indicators for monitoring progression of human immunodeficiency virus infection, Japanese journal of infectious diseases, January 2016, View Article
  58. Human T-lymphotropic virus type I (HTLV-1) infection among Iranian Blood donors: first case-control study on the risk factors, Viruses-Basel, November 2015, View Article
  59. Epidemiology of tobacco and substance abuse among university students in Mashhad, northeast of Iran, in 2008, Razavi International Journal of Medicine, August 2015, View Article
  60. Seropositivity of antibodies against hepatitis A virus in Mashhad, northeast of Iran, 2009: a cross-sectional community-based study, Razavi International Journal of Medicine, May 2015, View Article
  61. HTLV-1 infection as a serious health issue among Iranian multi-transfused patients: evidence from a systematic review and meta-analysis, Iranian Journal of Blood and Cancer (IJBC), March 2015, View Article
  62. Sexual and reproductive behaviors among undergraduate university students in Mashhad, a city in northeast of Iran, Journal of reproduction & infertility, Winter 2015, View Article
  63. Prevalence of human t-cell lymphotropic virus type 2 infection in general population of Mashhad, Iran, The Journal of Isfahan Medical Schoo, Winter 2015, View Article
  64. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran, Acta neurologica Belgica, December 2013, View Article
  65. Population movement and virus spreading: HEV spreading in a pilgrimage city, Mashhad in northeast Iran; an example, Hepatitis Monthly, August 2013, View Article
  66. No evidence of HTLV-2 infection among immonoblot indeterminate samples using nested pcr in Mashhad, northeast of Iran, Iranian Journal of Basic Medical Sciences, March 2013, View Article
  67. A Systematic review for estimation of HTLV-1 infection in the blood donors of iran, Iranian Journal of Basic Medical Sciences, March 2013, View Article
  68. Seroepidemiology of human T-cell lymphotropic virus type 1 infection in Iran: an overview, Journal of Medical Council of Iran, Winter 2013, View Article
  69. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis, AIDS Research and Human Retroviruses, September 2012, View Article
  70. Knowledge and attitudes of physicians in private practice towards HIV/AIDS in Mashhad, Iran, International Journal of STD & AIDS, August 2012, View Article
  71. High prevalence of HTLV-1 infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey, Journal of Clinical Virology, November 2011, View Article
  72. Epidemiology of HTLV-1 in Neyshabour, northeast of Iran, Iranian Red Crescent Medical Journal, June 2011, View Article
  73. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran, Hepatitis Monthly, May 2011, View Article
  74. Assessment of psychiatric symptoms using SCL-90-R among HIVAIDS individuals, Iranian Red Crescent Medical Journal, January   2011, View Article
  75. Knowledge of and attitudes towards HIV-AIDS in Mashhad, Islamic Republic of Iran, Eastern Mediterranean Health Journal, November -December 2008, View Article

بیشترین بازدید

اخبار و رویداد